$60,000 of ACADIA HEALTHCARE lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers."
You can find more data on corporate lobbying on Quiver Quantitative.
ACHC Hedge Fund Activity
We have seen 165 institutional investors add shares of ACHC stock to their portfolio, and 112 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 2,962,591 shares (+193.8%) to their portfolio in Q1 2026, for an estimated $69,295,003
- WELLINGTON MANAGEMENT GROUP LLP removed 2,701,366 shares (-22.9%) from their portfolio in Q1 2026, for an estimated $63,184,950
- GOLDMAN SACHS GROUP INC removed 2,488,185 shares (-52.6%) from their portfolio in Q1 2026, for an estimated $58,198,647
- MAK CAPITAL ONE LLC added 2,432,962 shares (+inf%) to their portfolio in Q1 2026, for an estimated $56,906,981
- CARRONADE CAPITAL MANAGEMENT, LP added 2,337,236 shares (+inf%) to their portfolio in Q1 2026, for an estimated $54,667,950
- KHROM CAPITAL MANAGEMENT LLC removed 2,156,409 shares (-29.3%) from their portfolio in Q1 2026, for an estimated $50,438,406
- INVENOMIC CAPITAL MANAGEMENT LP removed 2,129,712 shares (-64.3%) from their portfolio in Q1 2026, for an estimated $49,813,963
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ACHC Price Targets
Multiple analysts have issued price targets for $ACHC recently. We have seen 9 analysts offer price targets for $ACHC in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- A.J. Rice from UBS set a target price of $39.0 on 07/09/2026
- Brian Tanquilut from Jefferies set a target price of $30.0 on 06/03/2026
- Jason Cassorla from Guggenheim set a target price of $31.0 on 05/04/2026
- Ben Hendrix from RBC Capital set a target price of $31.0 on 05/04/2026
- Sarah James from Cantor Fitzgerald set a target price of $30.0 on 05/01/2026
- Andrew Mok from Barclays set a target price of $25.0 on 05/01/2026
- Ryan Langston from TD Cowen set a target price of $30.0 on 04/28/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Read full article here »
View the Zacks #1 Rank List
Lobbying Update: $60,000 of ACADIA HEALTHCARE lobbying was just disclosed
$60,000 of ACADIA HEALTHCARE lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers."
You can find more data on corporate lobbying on Quiver Quantitative.
ACHC Hedge Fund Activity
We have seen 165 institutional investors add shares of ACHC stock to their portfolio, and 112 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ACHC Price Targets
Multiple analysts have issued price targets for $ACHC recently. We have seen 9 analysts offer price targets for $ACHC in the last 6 months, with a median target of $30.0.
Here are some recent targets:
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Read full article here »